Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) EBT (2018 - 2019)

Historic EBT for DiaMedica Therapeutics (DMAC) over the last 2 years, with Q4 2019 value amounting to -$2.5 million.

  • DiaMedica Therapeutics' EBT fell 2668.71% to -$2.5 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$10.6 million, marking a year-over-year decrease of 8779.63%. This contributed to the annual value of -$24.4 million for FY2024, which is 2624.88% down from last year.
  • Per DiaMedica Therapeutics' latest filing, its EBT stood at -$2.5 million for Q4 2019, which was down 2668.71% from -$2.4 million recorded in Q3 2019.
  • Over the past 5 years, DiaMedica Therapeutics' EBT peaked at -$649000.0 during Q1 2018, and registered a low of -$3.2 million during Q1 2019.